0102030405
Crizotinib CAS No. 877399-52-5 Pharmaceutical Intermediates
02
introduction
Crizotinib is an oral medication classified as a targeted therapy for patients with non-small cell lung cancer (NSCLC) who have specific genetic mutations, particularly those involving the anaplastic lymphoma kinase (ALK) gene.
By inhibiting ALK and c-MET, Crizotinib effectively blocks the signaling pathways that lead to tumor growth and metastasis.
This targeted approach not only improves treatment outcomes but also minimizes damage to normal cells, making it a valuable option in cancer therapy.
By inhibiting ALK and c-MET, Crizotinib effectively blocks the signaling pathways that lead to tumor growth and metastasis.
This targeted approach not only improves treatment outcomes but also minimizes damage to normal cells, making it a valuable option in cancer therapy.
02
Physical and chemical properties
- Solubility: Crizotinib is soluble in organic solvents and has moderate solubility in water, facilitating its formulation into tablets and ensuring effective absorption in the gastrointestinal tract.
- Stability: The compound exhibits good stability under standard storage conditions, ensuring a longer shelf life and reliability in pharmaceutical applications.
These properties not only enhance the efficacy of Crizotinib in clinical settings but also contribute to its overall safety profile.
- Stability: The compound exhibits good stability under standard storage conditions, ensuring a longer shelf life and reliability in pharmaceutical applications.
These properties not only enhance the efficacy of Crizotinib in clinical settings but also contribute to its overall safety profile.
1. Targeted Cancer Therapy: Crizotinib specifically targets ALK and c-MET, providing a focused approach to inhibit cancer cell growth while sparing normal cells.
2. Proven Efficacy: Clinical trials have shown that Crizotinib significantly improves progression-free survival in patients with ALK-positive NSCLC compared to traditional chemotherapy.
3. Convenient Oral Administration: Available in capsule form, Crizotinib offers a convenient route of administration, improving patient compliance and ease of use.
4. Established Safety Profile: Crizotinib has undergone extensive clinical trials, providing a well-established safety profile when administered under proper medical supervision.
5. Regulatory Compliance: Our Crizotinib products adhere to all relevant regulatory standards, ensuring they are suitable for use in pharmaceutical applications worldwide.
2. Proven Efficacy: Clinical trials have shown that Crizotinib significantly improves progression-free survival in patients with ALK-positive NSCLC compared to traditional chemotherapy.
3. Convenient Oral Administration: Available in capsule form, Crizotinib offers a convenient route of administration, improving patient compliance and ease of use.
4. Established Safety Profile: Crizotinib has undergone extensive clinical trials, providing a well-established safety profile when administered under proper medical supervision.
5. Regulatory Compliance: Our Crizotinib products adhere to all relevant regulatory standards, ensuring they are suitable for use in pharmaceutical applications worldwide.
In addition to our high-quality Crizotinib, we also provide a range of laboratory equipment and supplies essential for pharmaceutical research and development. Our offerings include:
- High-Performance Liquid Chromatography (HPLC) Systems: Ideal for analyzing the purity and composition of pharmaceutical compounds, including Crizotinib.
- Mass Spectrometry (MS) Instruments: Essential for determining molecular weights and structural information of active pharmaceutical ingredients (APIs).
- Reagents and Solvents: A comprehensive selection of high-purity reagents and solvents to support various chemical reactions and analyses.
- High-Performance Liquid Chromatography (HPLC) Systems: Ideal for analyzing the purity and composition of pharmaceutical compounds, including Crizotinib.
- Mass Spectrometry (MS) Instruments: Essential for determining molecular weights and structural information of active pharmaceutical ingredients (APIs).
- Reagents and Solvents: A comprehensive selection of high-purity reagents and solvents to support various chemical reactions and analyses.
In conclusion, the Crizotinib is a vital compound for laboratories engaged in pharmaceutical and microbiological research. Its high purity, stability, and versatility make it an essential reagent for scientists seeking to advance their understanding of antibiotic mechanisms and resistance.
As a leading foreign trade company, we are committed to providing our clients with top-quality products and unparalleled support, ensuring that they can achieve their research goals efficiently and effectively.
Choosing our Crizotinib means partnering with a reliable supplier committed to quality, efficiency, and customer satisfaction.
Contact us today to learn more about how our Crizotinib can enhance your drug development processes and contribute to your success in the pharmaceutical market.
As a leading foreign trade company, we are committed to providing our clients with top-quality products and unparalleled support, ensuring that they can achieve their research goals efficiently and effectively.
Choosing our Crizotinib means partnering with a reliable supplier committed to quality, efficiency, and customer satisfaction.
Contact us today to learn more about how our Crizotinib can enhance your drug development processes and contribute to your success in the pharmaceutical market.